Centre Hospitalier Universitaire De Dijon
- Address
- 1 Boulevard Jeanne D Arc, Bp 77908
Sponsor Overview
Specializations
Gastrointestinal oncology
Clinical research includes colorectal cancer, rectal cancer, small bowel adenocarcinoma, and ampullary adenocarcinoma, with interest in neoadjuvant and adjuvant chemotherapy, ctDNA-guided treatment, and surgery-related cancer care. Studies also extend to advanced gastroenteropancreatic neuroendocrine carcinoma.
- Colorectal cancer
- Rectal cancer
- Small bowel adenocarcinoma
- Ampullary adenocarcinoma
The sponsor is active in perioperative and post-surgical oncology, including strategies linked to microsatellite instability and mismatch repair deficiency.
Endocrinology and metabolic disease
Research activity covers type 1 diabetes with double diabetes features, focusing on glycaemic control and metabolic management. The portfolio also includes rare familial polycythemia associated with an EPO gene mutation.
- Type 1 diabetes
- Double diabetes
- Familial polycythemia
- EPO gene mutation
These studies reflect interest in complex metabolic phenotypes and inherited haematologic conditions.
Ophthalmology
The sponsor funds trials in diabetic macular oedema and macular telangiectasia type 1, with attention to retinal thickness, visual outcomes, and intravitreal treatment options. Research also addresses resistant retinal disease in people with diabetes.
- Diabetic macular oedema
- Macular telangiectasia type 1
- Retinal disease
- Intravitreal therapy
Its ophthalmic work spans both diabetic and non-diabetic retinal disorders.
Rheumatology and inflammatory disease
Clinical studies include giant cell arteritis and treatment strategies involving tocilizumab and methotrexate. The portfolio also includes autoimmune hemolytic anemia and aspirin use in acute pneumonia.
- Giant cell arteritis
- Autoimmune hemolytic anemia
- Inflammatory disease
- Acute pneumonia
These trials show interest in immune-mediated disease control and complications of systemic inflammation.
Critical care, urology, and neurological disorders
Research extends to vasoplegic syndrome, norepinephrine-refractory vasoplegic shock, and perioperative haemodynamic management in cardiac surgery. Additional studies address recurrent urinary tract infections, neurogenic bladder, and rare neurological conditions including TBR1-related neurocognitive disorder and Megalencephaly-CApillary malformation Polymicrogyria syndrome.
- Vasoplegic syndrome
- Refractory vasoplegic shock
- Neurogenic bladder
- TBR1-related neurocognitive disorder
The sponsor also studies idiopathic pulmonary fibrosis, broadening its interest in severe respiratory disease.
Sponsored Trials
Data & Insights
This sponsor works with 35 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 264 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases6 trials280 other sponsors
- 2.Immune System Diseases3 trials322 other sponsors
- 3.Neoplasms3 trials853 other sponsors
- 4.Anesthesia and Analgesia2 trials100 other sponsors
- 5.Eye Diseases2 trials138 other sponsors
- 6.Genetic Phenomena2 trials26 other sponsors
- 7.Respiratory Tract Diseases2 trials277 other sponsors
- 8.Bacterial Infections and Mycoses1 trial180 other sponsors
- 9.Digestive System and Oral Physiological Phenomena1 trial16 other sponsors
- 10.Hemic and Lymphatic Diseases1 trial249 other sponsors
- 11.Immune system processes1 trial65 other sponsors
- 12.Nutritional and Metabolic Diseases1 trial211 other sponsors
Partnered Research Centres
264 centres- Address
- 264 Boulevard de Saint Pierre, 13005 Marseille
- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- 27 Rue du Faubourg Saint-Jacques, 75014 Paris
- Address
- 46 Rue Henri Huchard, 75877 Paris
- Address
- Num Voie 47 A 83, 47 Boulevard De L Hopital, 75013 Paris
- Address
- 26 Avenue Du Docteur Arnold Netter, 75012 Paris
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Centre Hospitalier Universitaire De Dijon.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.